AAAAAA

   
Results: 1-8 |
Results: 8
High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience
Authors: Dowling, AJ Prince, HM Wirth, A Wolf, M Januszewicz, EH Juneja, S Seymour, JF Gates, P Smith, JG
Citation: Aj. Dowling et al., High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience, INTERN M J, 31(5), 2001, pp. 279-289
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxelwith peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study
Authors: Prince, HM Rischin, D Toner, GC Seymour, JF Blakey, D Gates, P Eerhard, S Chapple, P Quinn, M Brettell, M Juneja, S Wolf, M Januszewicz, EH Richardson, G Scarlett, J Briggs, P
Citation: Hm. Prince et al., Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxelwith peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study, BONE MAR TR, 26(9), 2000, pp. 955-961
Docetaxel effectively mobilizes peripheral blood CD34(+) cells
Authors: Prince, HM Toner, GC Seymour, JF Blakey, D Gates, P Eerhard, S Chapple, P Wall, D Quinn, M Juneja, S Wolf, M Januszewicz, EH Richardson, G Scarlett, J Briggs, P Brettell, M Rischin, D
Citation: Hm. Prince et al., Docetaxel effectively mobilizes peripheral blood CD34(+) cells, BONE MAR TR, 26(5), 2000, pp. 483-487
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel withperipheral blood progenitor cell and filgrastim support for metastatic andlocally advanced breast cancer: Results of a phase I study
Authors: Prince, HM Millward, MJ Rischin, D Blakey, D Francis, P Gates, P Chapple, P Quinn, M Juneja, S Wolf, M Januszewicz, EH Seymour, JF Brettell, M Strickland, A Zalcberg, J Richardson, G Scarlett, J Briggs, P Toner, GC
Citation: Hm. Prince et al., Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel withperipheral blood progenitor cell and filgrastim support for metastatic andlocally advanced breast cancer: Results of a phase I study, ANN ONCOL, 10(4), 1999, pp. 479-481
Hodgkin's disease type Richter's syndrome in chronic lymphocytic leukemia
Authors: Juneja, S Carney, D Ellis, D Januszewicz, EH Wolf, M Prince, HM
Citation: S. Juneja et al., Hodgkin's disease type Richter's syndrome in chronic lymphocytic leukemia, LEUKEMIA, 13(5), 1999, pp. 826-827
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer
Authors: Prince, HM Gardyn, J Millward, MJ Rischin, D Francis, P Gates, P Chapple, P Quinn, M Juneja, S Wolf, M Januszewicz, EH Richardson, G Scarlett, J Briggs, P Brettell, M Toner, GC
Citation: Hm. Prince et al., Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer, BONE MAR TR, 23(5), 1999, pp. 427-435
Correlation of cytogenetics, BCR-ABL PCR studies and fluorescence in situ hybridisation (FISH) in adult acute lymphoblastic leukaemia
Authors: Campbell, LJ White, JS Martinow, A Rayeroux, KC Michael, PM Januszewicz, EH
Citation: Lj. Campbell et al., Correlation of cytogenetics, BCR-ABL PCR studies and fluorescence in situ hybridisation (FISH) in adult acute lymphoblastic leukaemia, AUST NZ J M, 29(5), 1999, pp. 707-712
Fludarabine and high dose cytarabine (FLA): a well tolerated salvage regimen in acute myeloid leukaemia
Authors: Strickland, AH Seymour, C Prince, HM Wolf, M Juneja, S Januszewicz, EH
Citation: Ah. Strickland et al., Fludarabine and high dose cytarabine (FLA): a well tolerated salvage regimen in acute myeloid leukaemia, AUST NZ J M, 29(4), 1999, pp. 556-558
Risultati: 1-8 |